Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Ibα complex reveals conformation differences with a complex bearing von Willebrand disease mutations

被引:160
作者
Dumas, JJ [1 ]
Kumar, R [1 ]
McDonagh, T [1 ]
Sullivan, F [1 ]
Stahl, ML [1 ]
Somers, WS [1 ]
Mosyak, L [1 ]
机构
[1] Wyeth, Dept Chem & Screening Sci, Cambridge, MA 02140 USA
关键词
D O I
10.1074/jbc.M401659200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The adhesion of platelets to the subendothelium of blood vessels at sites of vascular injury under high shear conditions is mediated by a direct interaction between the platelet receptor glycoprotein Ibalpha (GpIbalpha) and the A1 domain of the von Willebrand factor (VWF). Here we report the 2.6-Angstrom crystal structure of a complex comprised of the extracellular domain of GpIbalpha and the wild-type A1 domain of VWF. A direct comparison of this structure to a GpIbalpha-A1 complex containing "gain-of-function" mutations, A1-R543Q and GpIbalpha-M239V, reveals specific structural differences between these complexes at sites near the two GpIbalpha-A1 binding interfaces. At the smaller interface, differences in interaction show that the alpha1-beta2 loop of A1 serves as a conformational switch, alternating between an open alpha1-beta2 isomer that allows faster dissociation of GpIbalpha-A1, as observed in the wild-type complex, and an extended isomer that favors tight association as seen in the complex containing A1 with a type 2B von Willebrand Disease (VWD) mutation associated with spontaneous binding to GpIbalpha. At the larger interface, differences in interaction associated with the GpIbalpha-M239V platelet-type VWD mutation are minor and localized but feature discrete gamma-turn conformers at the loop end of the beta-hairpin structure. The beta-hairpin, stabilized by a strong classic gamma-turn as seen in the mutant complex, relates to the increased affinity of A1 binding, and the beta-hairpin with a weak inverse gamma-turn observed in the wild-type complex corresponds to the lower affinity state of GpIbalpha. These findings provide important details that add to our understanding of how both type 2B and platelet-type VWD mutations affect GpIbalpha-A1 binding affinity.
引用
收藏
页码:23327 / 23334
页数:8
相关论文
共 63 条
[1]   CROSS-LINKING OF A MONOMERIC 39/34-KDA DISPASE FRAGMENT OF VONWILLEBRAND-FACTOR (LEU-480/VAL-481-GLY-718) TO THE N-TERMINAL REGION OF THE ALPHA-CHAIN OF MEMBRANE GLYCOPROTEIN-IB ON INTACT PLATELETS WITH BIS(SULFOSUCCINIMIDYL) SUBERATE [J].
ANDREWS, RK ;
GORMAN, JJ ;
BOOTH, WJ ;
CORINO, GL ;
CASTALDI, PA ;
BERNDT, MC .
BIOCHEMISTRY, 1989, 28 (21) :8326-8336
[2]   Molecular mechanisms of platelet adhesion and activation [J].
Andrews, RK ;
Lopez, JA ;
Berndt, MC .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1997, 29 (01) :91-105
[3]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[4]   IDENTIFICATION OF ASPARTIC ACID-514 THROUGH GLUTAMIC ACID-542 AS A GLYCOPROTEIN-IB-IX COMPLEX RECEPTOR RECOGNITION SEQUENCE IN VONWILLEBRAND-FACTOR - MECHANISM OF MODULATION OF VONWILLEBRAND-FACTOR BY RISTOCETIN AND BOTROCETIN [J].
BERNDT, MC ;
WARD, CM ;
BOOTH, WJ ;
CASTALDI, PA ;
MAZUROV, AV ;
ANDREWS, RK .
BIOCHEMISTRY, 1992, 31 (45) :11144-11151
[5]  
Berndt MC, 2001, THROMB HAEMOSTASIS, V86, P178
[6]  
Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
[7]  
BUDDE U, 2001, REV CLIN EXP HEMATOL, V4, P335
[8]   RIBBONS 2 0 [J].
CARSON, M .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1991, 24 :958-&
[9]   Epitope mapping of inhibitory antibodies against platelet glycoprotein Ibα reveals interaction between the leucine-rich repeat N-terminal and C-terminal flanking domains of glycoprotein Ibα [J].
Cauwenberghs, N ;
Vanhoorelbeke, K ;
Vauterin, S ;
Westra, DF ;
Rome, G ;
Huizinga, EG ;
Lopez, JA ;
Berndt, MC ;
Harsfalvi, J ;
Deckmyn, H .
BLOOD, 2001, 98 (03) :652-660
[10]  
Celikel R, 2000, NAT STRUCT BIOL, V7, P881